Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells

被引:15
作者
Beirnaert, E
De Zutter, S
Janssens, W
van der Groen, G
机构
[1] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium
[2] Univ Ghent VIB, B-9052 Ghent, Belgium
关键词
D O I
10.1006/viro.2000.0802
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Gp160-directed antibody-mediated neutralization is thought to function by at least two different mechanisms that impair virus entry into the host cell: inhibition of virus attachment and inhibition of virus-cell membrane fusion. Previously, the neutralization spectra of sera derived from human immunodeficiency virus type 1 (HIV-1) infected patients were determined using 17 primary isolates belonging to HIV-1 group M (env clades A-H) and group O. The sera could be categorized as potent broad cross-neutralizing, limited cross-neutralizing, and nonneutralizing sera. The aim of this study was to examine whether the neutralizing capacity of polyclonal human sera correlates with their capacity to inhibit the attachment of infectious virions to the surface of peripheral blood mononuclear cells. A 100% correlation was found between the broad cross-neutralizing capacity and the ability to inhibit binding of primary isolates belonging to different genetic clades and groups to peripheral blood mononuclear cells. These results may indicate that broad cross-neutralizing antibodies are directed against those conserved regions on gp120 that interact with the cell receptor(s) and that those antibodies can therefore interfere with the binding of virus to the host cell. (C) 2001 Academic Press.
引用
收藏
页码:305 / 314
页数:10
相关论文
共 32 条
  • [1] BAHRAOUI E, 1988, AIDS, V2, P165
  • [2] Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions
    Bastiani, L
    Laal, S
    Kim, M
    ZollaPazner, S
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (05) : 3444 - 3450
  • [3] Beirnaert E, 2000, J MED VIROL, V62, P14, DOI 10.1002/1096-9071(200009)62:1&lt
  • [4] 14::AID-JMV3&gt
  • [5] 3.0.CO
  • [6] 2-L
  • [7] Burton DR, 1997, AIDS, V11, pS87
  • [8] Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage
    Cecilia, D
    Kewalramani, VN
    O'Leary, J
    Volsky, B
    Nyambi, P
    Burda, S
    Xu, S
    Littman, DR
    Zolla-Pazner, S
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (09) : 6988 - 6996
  • [9] UPDATE ON THE NEUTRALIZATION OF ANIMAL VIRUSES
    DIMMOCK, NJ
    [J]. REVIEWS IN MEDICAL VIROLOGY, 1995, 5 (03) : 165 - 179
  • [10] DIMMOCK NJ, 1993, CURR TOP MICROBIOL, V183, P1